Active, Not Recruiting
Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors
NCT05945823
- Conditions
- Adenocarcinoma Of Esophagus, Carcinoma, Carcinoma, Squamous Cell, +22 more
- Locations
-
- University of California Los Angeles UCLA - Cancer Care - Santa Monica Santa Monica, California, United States
- Rocky Mountain Cancer Centers Midtown Denver, Colorado, United States
- Mount Sinai Comprehensive Cancer Center Miami Beach, Florida, United States
- Moffitt Cancer Center and Research Institute Tampa, Florida, United States